Factors influencing the properties of rifampicin liposome and applications for dry powder inhaler

Proceedings of the 2nd IEEE International Conference on Nano/Micro Engineered and Molecular Systems, IEEE NEMS 2007

Volumn , Issue , 2007, Pages 1104-1109

  Changsan, Narumon ^a   Srichana, Teerapol ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

Dry powder inhaler; Liposome; Rifampicin

Indexed keywords

AEROSOLS; CHOLESTEROL; ENCAPSULATION; MACROPHAGES; PH EFFECTS; POWDERS;

ALVEOLAR MACROPHAGES; DRY POWDER INHALERS; RIFAMPICIN;

LIPOSOMES;

EID: 34548140490     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/NEMS.2007.352211     Document Type: Conference Paper

References (29)

1. S. Singh, "Tuberculosis," Curr. Anaesth & Crit Care., vol. 15, pp. 165-171, 2004.
2. T. R. Frieden, T. R. Sterling, S. S. Munstiff, C. J. Watt, and C. Dye, "Tuberculosis," Lancet., vol. 362, pp. 887-89, 2003.
3. F. Ahsan, I. P. Rivas, M. A. Khan and A. I. Torres Suarez, "Targeting to macrophages: role of physicochemical properties of particulate carriers-liposomes and microspheres-on the phagocytosis by macrophages," J. Controlled Release., vol. 79, pp. 29-40, 2002.
4. P. Couvreur, E. Fattal and A. Andremont, "Liposomes and nanoparticle in the treatment of intracellular bacterial infections," Pharm. Res., vol. 8, no.9, pp. 1079-1086, 1991.
5. S. Dutta, R. Karki, P.G. Shivananda, and N. Udupa, "Liposome encapsulated rifampicin and isoniazid," Indian J. Pharm. Sciences., vol. 62, pp. 384-387, 2000.
6. M. Dutt, and G.K. Khuller, "Liposomes and PLG microparticles as sustained release antitubercular drug carriers - an in vitro- in vivo study," Int. J. Antimicrob. Agents., vol. 18, pp. 245-252, 2001
7. P. Deol and G.K. Khuller, "Lung specific stealth liposomes: stability, biodistribution and toxicity of liposomal antitubercular drugs in mice," Biochim. Biophys. Acta., vol. 1334, pp. 161-172, 1997.
8. P. Deol, G.K. Khuller, and K. Joshi, "Therapeutic efficacies of isoniazid and rifampicin encapsulated in lung-specific stealth liposomes against Mycobacterium tuberculosis infection induced in mice," Antimicrob. Agents Chemother., vol. 41, no.6, pp. 1211-1214, 2001.
9. S. Labana, R. Pandey, S. Sharma and G. K. Khuller, "Chemotherapeutic activity against murine tuberculosis of once weekly administered drugs (isoniazid and rifampicin) encapsulated in liposomes," Int. J. Antimicrob. Agents., vol.20, pp. 301-304, 2002.
10. E.L.W Barrow, G.A. Winchester, J.K. Staas, D.C Quenelle and W.W. Barrow, "Use of microsphere technology for targeted delivery of rifampicin to Mycobacterium tuberculosis-infected macrophages," Antimicrob. Agents Chemother., vol. 42, pp. 2682-2689, 1998.
11. D.C. Quenelle, J.K. Stass, G.A. Winchester, E.L. Barrow and W.W. Barrow, "Efficacy of microencapsulated rifampicin in Mycobacterium tuberculosis - infected mice," Antimicrob. Agents Chemother., vol. 43, pp. 1144-1151, 1999.
12. M. Dutt, and G.K. Khuller, "Chemotherapy of Mycobacterium tuberculosis infections in mice with a combination of isoniazid and rifampicin entrapped in Poly (DL-lactide-co-glycolide) microparticles," J. Antimicrob. Chemother., vol. 47, pp. 829-835, 2001.
13. Q. Ain, S. Sharma and G.K. Khuller, "Chemotherapeutic potential of orally administered Poly(Lactide-co-Glycolide) microparticle containing isoniazid, rifampin, and pyrazinamide against experimental tuberculosis," Antimicrob. Agents Chemother., vol. 47, pp. 3305-3307, 2003.
14. R. Pandey, A. Zahoor, S. Sharma and G.K. Khuller, "Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis," Tuberculosis., vol. 83, pp. 373-378, 2003.
15. A. Sharma, R. Pandey, S. Sharma and G.K. Khuller, "Chemotherapeutic efficacy of Poly (DL-Lactide-Co-Glycolide) nanoparticle encapsulated antitubercular drugs at sub-therapeutic dose against experimental tuberculosis" Int. J. Antimicrob. Agent., vol. 24, pp. 599-604, 2004.
16. Q. Ain, S. Sharma, G.K. Khuller, and S. K. Garg, "Alginate-based oral drug delivery for tuberculosis: pharmacokinetics and therapeutic effects," J. Antimicrob Chemother., vol. 51, pp. 931-938, 2003.
17. R. Pandey and G.K. Khuller, "Chemotherapeutic potential of alginate-chitosan microspheres as antitubercular drug carriers," J. Antimicrob Chemother., vol. 53, pp. 635-640, 2004.
18. S.P. Vyas, M.E. Kannan, S. Jain, V. Mishra and P. Singh, " Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophage," Int. J. Pharm., vol. 269, pp. 37-49, 2004.
19. N. Rooijen and A. Sanders, "The macrophage as target or obstacle in liposome-based targeting strategies," Int. J. Pharm., vol. 162, pp. 45-50, 1998.
20. R. Sharma, D. Saxena, A.K. Dwivedi, and A. Misra, "Inhalable microparticle containing drug combinations to target alveolar macrophage for treatment of pulmonary tuberculosis." Pharm. Res., vol. 18, pp. 1405- 1410, 2001.
21. S. Suarez, P. O' Hara, M. Kazantsava, C.E. Newcomer, R. Hofter, D.N. McMurray, and A.J. Hickey, " Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: Screening in an infectious disease model," Pharm. Res., vol. 18, pp.1315-1319. 2001.
22. F. Emmen and G. Storm, "Liposomes in treatment of infectious disease," Pharmaceutisch Weekblad Scientific Edition., vol. 9, pp. 162-171, 1987.
23. P. M. Frederik and D. H. W. Hubert, "Cryoelectron microscopy of liposomes," Methods of Enzymol., vol. 391, pp. 431-448, 2005.
24. T. Srichana, R. Suedee, and P. Srisudjai, "Application of spectrofluorometry for evaluation of dry powder inhalers in vitro," Pharmazie., vol. 58, pp. 125-129, 2003.
25. K. Punturee, C P. Wild and U. Vinitketkumneun, "Thai medicinal plants modulate nitric oxide and necrosis factor-α in J 774.2 mouse macrophages," J. Ethanopharmacol., vol. 95, pp. 183-189, 2004.
26. http://www2.chemie.uni-enlargen.de
27. R. R. C. New, "Introduction," in Liposomes; a practical approach, R. R. C New, Ed. New York, IRL press, 1990 pp. 1-32.
28. M. Cherian and E. Corona, "Lyophilisation of biologicals," Bioprocessing and biopartnering, pp. 1-5, 2006. Available: http://patheon. com
29. W.Q. Sun, A.C. Leopold, L.M. Crowe and J.H. Crowe. "Stability of dry liposomes in sugar glasses," Biophys J., vol. 70, pp. 1769-1776, 1996.